Advances in the Management of Melanoma
Sign Up to like & getrecommendations! Published in 2017 at "Current Dermatology Reports"
DOI: 10.1007/s13671-017-0202-9
Abstract: Purpose of ReviewStage IV melanoma is an aggressive malignancy with the median survival historically being less than 1 year. Approximately 50% of melanomas contain an activating mutation in a targetable component of the mitogen-activated protein kinase… read more here.
Keywords: melanoma; management melanoma; stage iii; advances management ... See more keywords